 Abraham Nussbaum
Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physician-Patient Relations | 6 | 2020 | 517 | 1.530 |
Why?
| | Religion and Medicine | 3 | 2019 | 28 | 1.450 |
Why?
| | Depressive Disorder, Major | 3 | 2020 | 327 | 1.220 |
Why?
| | Psychiatry | 3 | 2020 | 216 | 1.190 |
Why?
| | Antipsychotic Agents | 5 | 2017 | 197 | 1.170 |
Why?
| | Isoxazoles | 3 | 2012 | 57 | 1.110 |
Why?
| | Marijuana Smoking | 3 | 2014 | 228 | 1.040 |
Why?
| | Mental Disorders | 4 | 2020 | 976 | 0.990 |
Why?
| | Clergy | 3 | 2019 | 14 | 0.970 |
Why?
| | Literature, Modern | 2 | 2014 | 3 | 0.950 |
Why?
| | Schizophrenia | 4 | 2012 | 509 | 0.880 |
Why?
| | Palmitates | 2 | 2012 | 19 | 0.830 |
Why?
| | Medical Marijuana | 2 | 2014 | 103 | 0.830 |
Why?
| | Vaccination Refusal | 2 | 2020 | 69 | 0.820 |
Why?
| | Vaccination | 3 | 2020 | 1241 | 0.780 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2020 | 250 | 0.780 |
Why?
| | Faith-Based Organizations | 1 | 2021 | 2 | 0.760 |
Why?
| | Cannabis | 3 | 2020 | 402 | 0.760 |
Why?
| | Medicine in Literature | 3 | 2016 | 4 | 0.740 |
Why?
| | Marijuana Abuse | 2 | 2014 | 212 | 0.730 |
Why?
| | Mass Vaccination | 1 | 2019 | 18 | 0.650 |
Why?
| | Smallpox | 1 | 2018 | 7 | 0.650 |
Why?
| | Philosophy, Medical | 1 | 2018 | 6 | 0.650 |
Why?
| | Smallpox Vaccine | 1 | 2018 | 24 | 0.640 |
Why?
| | Occupations | 1 | 2018 | 40 | 0.640 |
Why?
| | Motivational Interviewing | 1 | 2020 | 93 | 0.640 |
Why?
| | Psychotic Disorders | 2 | 2017 | 153 | 0.580 |
Why?
| | Hospitals, Psychiatric | 1 | 2017 | 19 | 0.580 |
Why?
| | Professional Role | 1 | 2019 | 168 | 0.580 |
Why?
| | Dronabinol | 3 | 2017 | 127 | 0.580 |
Why?
| | Physicians | 3 | 2018 | 836 | 0.550 |
Why?
| | Leadership | 2 | 2019 | 330 | 0.550 |
Why?
| | Internship and Residency | 2 | 2020 | 1083 | 0.540 |
Why?
| | Inpatients | 2 | 2017 | 414 | 0.530 |
Why?
| | Psychiatric Department, Hospital | 1 | 2016 | 19 | 0.520 |
Why?
| | Prescription Drug Diversion | 1 | 2014 | 10 | 0.480 |
Why?
| | Phytotherapy | 2 | 2013 | 71 | 0.480 |
Why?
| | Marijuana Use | 1 | 2017 | 171 | 0.460 |
Why?
| | Attitude to Death | 1 | 2014 | 69 | 0.460 |
Why?
| | Patient Readmission | 2 | 2017 | 694 | 0.440 |
Why?
| | Legislation, Drug | 1 | 2014 | 80 | 0.440 |
Why?
| | Practice Patterns, Physicians' | 2 | 2020 | 1280 | 0.440 |
Why?
| | Religion and Psychology | 1 | 2012 | 28 | 0.420 |
Why?
| | Writing | 1 | 2014 | 91 | 0.410 |
Why?
| | Length of Stay | 1 | 2017 | 1077 | 0.410 |
Why?
| | Mental Health | 2 | 2020 | 594 | 0.400 |
Why?
| | Depression | 1 | 2020 | 1236 | 0.400 |
Why?
| | Psychoanalytic Therapy | 1 | 2011 | 10 | 0.390 |
Why?
| | Plant Preparations | 1 | 2011 | 23 | 0.390 |
Why?
| | Drug Approval | 1 | 2011 | 82 | 0.370 |
Why?
| | Communication | 1 | 2016 | 801 | 0.370 |
Why?
| | Residence Characteristics | 1 | 2012 | 317 | 0.350 |
Why?
| | Antidepressive Agents | 1 | 2011 | 202 | 0.340 |
Why?
| | Prescription Drugs | 1 | 2011 | 117 | 0.340 |
Why?
| | Humans | 26 | 2021 | 125131 | 0.330 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 1970 | 0.320 |
Why?
| | Mental Health Services | 1 | 2012 | 345 | 0.310 |
Why?
| | Suicide, Attempted | 1 | 2011 | 335 | 0.310 |
Why?
| | Suicide | 1 | 2014 | 526 | 0.300 |
Why?
| | Paliperidone Palmitate | 3 | 2012 | 4 | 0.290 |
Why?
| | Colorado | 5 | 2020 | 4471 | 0.260 |
Why?
| | Alzheimer Disease | 1 | 2011 | 529 | 0.260 |
Why?
| | Pyrimidines | 1 | 2008 | 391 | 0.240 |
Why?
| | History, 20th Century | 2 | 2018 | 290 | 0.240 |
Why?
| | History, 21st Century | 2 | 2014 | 181 | 0.210 |
Why?
| | Risperidone | 2 | 2012 | 27 | 0.200 |
Why?
| | Education, Medical | 2 | 2016 | 255 | 0.200 |
Why?
| | Commitment of Mentally Ill | 1 | 2020 | 13 | 0.180 |
Why?
| | Living Wills | 1 | 2020 | 8 | 0.180 |
Why?
| | Refusal to Treat | 1 | 2020 | 20 | 0.180 |
Why?
| | Observer Variation | 1 | 2020 | 330 | 0.170 |
Why?
| | Freedom | 1 | 2019 | 12 | 0.170 |
Why?
| | Vaccination Coverage | 1 | 2020 | 63 | 0.170 |
Why?
| | History, 18th Century | 1 | 2018 | 24 | 0.160 |
Why?
| | History, 19th Century | 1 | 2018 | 62 | 0.160 |
Why?
| | Trust | 1 | 2019 | 114 | 0.150 |
Why?
| | Evidence-Based Practice | 1 | 2020 | 198 | 0.150 |
Why?
| | Science | 1 | 2018 | 54 | 0.150 |
Why?
| | Cues | 1 | 2019 | 315 | 0.140 |
Why?
| | Anti-Anxiety Agents | 1 | 2017 | 52 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2012 | 1324 | 0.140 |
Why?
| | Public Health | 1 | 2021 | 493 | 0.130 |
Why?
| | Risk Factors | 3 | 2016 | 9549 | 0.130 |
Why?
| | Male | 6 | 2018 | 60792 | 0.120 |
Why?
| | Female | 7 | 2017 | 64889 | 0.120 |
Why?
| | Vaccines | 1 | 2019 | 380 | 0.110 |
Why?
| | Curriculum | 1 | 2020 | 943 | 0.110 |
Why?
| | Humanism | 1 | 2013 | 9 | 0.110 |
Why?
| | Treatment Outcome | 4 | 2017 | 9790 | 0.110 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 281 | 0.110 |
Why?
| | Adult | 4 | 2017 | 33167 | 0.110 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3047 | 0.110 |
Why?
| | Odds Ratio | 1 | 2016 | 1050 | 0.110 |
Why?
| | Pandemics | 1 | 2021 | 1434 | 0.100 |
Why?
| | Psychoanalytic Interpretation | 1 | 2011 | 1 | 0.100 |
Why?
| | Physical Examination | 1 | 2013 | 256 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2014 | 6936 | 0.100 |
Why?
| | Medicine | 1 | 2013 | 112 | 0.100 |
Why?
| | Dibenzothiazepines | 1 | 2011 | 19 | 0.100 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1183 | 0.100 |
Why?
| | Combined Modality Therapy | 2 | 2011 | 1200 | 0.100 |
Why?
| | Ethylene Glycol | 1 | 2011 | 13 | 0.100 |
Why?
| | Drug and Narcotic Control | 1 | 2011 | 28 | 0.100 |
Why?
| | Middle Aged | 3 | 2017 | 29112 | 0.090 |
Why?
| | Drug Substitution | 1 | 2011 | 48 | 0.090 |
Why?
| | Suicidal Ideation | 1 | 2016 | 427 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1635 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2016 | 658 | 0.090 |
Why?
| | Hypercholesterolemia | 1 | 2011 | 100 | 0.090 |
Why?
| | Benzodiazepines | 1 | 2011 | 126 | 0.090 |
Why?
| | Young Adult | 2 | 2017 | 11384 | 0.090 |
Why?
| | Sex Factors | 1 | 2016 | 1901 | 0.090 |
Why?
| | Quinolones | 1 | 2011 | 102 | 0.090 |
Why?
| | United States | 3 | 2019 | 13613 | 0.080 |
Why?
| | Adolescent | 2 | 2020 | 19411 | 0.080 |
Why?
| | Pain | 2 | 2013 | 767 | 0.080 |
Why?
| | Piperazines | 1 | 2011 | 331 | 0.080 |
Why?
| | Prevalence | 1 | 2014 | 2488 | 0.080 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 133 | 0.070 |
Why?
| | Delayed-Action Preparations | 1 | 2008 | 163 | 0.070 |
Why?
| | Neuropsychological Tests | 1 | 2011 | 1084 | 0.070 |
Why?
| | Child, Preschool | 1 | 2020 | 9938 | 0.070 |
Why?
| | Chronic Disease | 1 | 2011 | 1684 | 0.060 |
Why?
| | Prospective Studies | 1 | 2016 | 6818 | 0.060 |
Why?
| | Pennsylvania | 1 | 2019 | 107 | 0.040 |
Why?
| | State Government | 1 | 2019 | 43 | 0.040 |
Why?
| | Government Regulation | 1 | 2019 | 50 | 0.040 |
Why?
| | Aged | 1 | 2014 | 20859 | 0.030 |
Why?
| | Attitude to Health | 1 | 2019 | 427 | 0.030 |
Why?
| | Qualitative Research | 1 | 2019 | 1021 | 0.030 |
Why?
| | Spasm | 1 | 2013 | 19 | 0.030 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2013 | 30 | 0.030 |
Why?
| | Quetiapine Fumarate | 1 | 2011 | 27 | 0.020 |
Why?
| | Aripiprazole | 1 | 2011 | 19 | 0.020 |
Why?
| | Pediatrics | 1 | 2019 | 1046 | 0.020 |
Why?
| | Diet, Reducing | 1 | 2011 | 84 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2011 | 341 | 0.020 |
Why?
| | Cholesterol | 1 | 2011 | 390 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2011 | 537 | 0.020 |
Why?
| | Triglycerides | 1 | 2011 | 551 | 0.020 |
Why?
| | Risk | 1 | 2011 | 896 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1006 | 0.020 |
Why?
| | Body Weight | 1 | 2011 | 959 | 0.020 |
Why?
| | Body Mass Index | 1 | 2011 | 2174 | 0.010 |
Why?
| | Exercise | 1 | 2011 | 1779 | 0.010 |
Why?
| | Animals | 1 | 2013 | 34345 | 0.010 |
Why?
|
|
Nussbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|